Specific Antibody Profile in Human Brucellosis
The results of classic serological tests were compared with those of enzyme-linked immunosor-bent assay in studies of immunoglobulins to Brucella in 761 serum samples from 75 patients with brucellosis. Except for five instances involving the IgM ELISA, all serological tests gave positive results at...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 1992-01, Vol.14 (1), p.131-140 |
|---|---|
| Hauptverfasser: | , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 140 |
|---|---|
| container_issue | 1 |
| container_start_page | 131 |
| container_title | Clinical infectious diseases |
| container_volume | 14 |
| creator | Ariza, J. Pellicer, T. Pallarés, R. Foz, A. Gudiol, F. |
| description | The results of classic serological tests were compared with those of enzyme-linked immunosor-bent assay in studies of immunoglobulins to Brucella in 761 serum samples from 75 patients with brucellosis. Except for five instances involving the IgM ELISA, all serological tests gave positive results at admission. Among the 63 patients without relapse, rates of persistent ELISA positivity (determined by the Kaplan-Meier method) 12 months after therapy were 25% for IgM, 69% for IgA, and 89% for IgG. Among the 12 patients with relapse, a second peak of ELISA IgG and IgA was often detected. The persistence of high serum antibody titers in patients without relapse was due mainly to IgG and was often associated with high titers at admission or with the presence of focal disease. Overall, serological changes were better detected by ELISA than by classic serological tests. While a second peak of ELISA IgG and IgA is a good marker of relapse, the persistence of high titers of IgG by itself is not a good predictor of chronic infection. |
| doi_str_mv | 10.1093/clinids/14.1.131 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72909644</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4456252</jstor_id><sourcerecordid>4456252</sourcerecordid><originalsourceid>FETCH-LOGICAL-c450t-6847355ceb211a82ad73e3d4d10f6dcdbcaff634fc29b2c336761efd72ed0b303</originalsourceid><addsrcrecordid>eNqFkM1Lw0AUxBdRaq3ePSjk5C3tvuxXcqzFWrGiUAXxsiT7AVvTpO4mYP97W1Pq0dMb-M0Mj0HoEvAQcEZGqnSV02EEdAhDIHCE-sCIiDnL4HirMUtjmpL0FJ2FsMQYIMWsh3rABFAQfTRcrI1y1qloXDWuqPUmevG1daWJXBXN2lVeRbe-VaYs6-DCOTqxeRnMxf4O0Nv07nUyi-fP9w-T8TxWlOEm5ikVhDFligQgT5NcC2KIphqw5VrpQuXWckKtSrIiUYRwwcFYLRKjcUEwGaCbrnft66_WhEauXNg9kVemboMUSYYzTum_RuCQpozA1og7o_J1CN5YufZulfuNBCx3W8r9lhKoBAm_ket9d1usjP4LdONt-VXHl6Gp_QFTynjCki2OO-xCY74POPefkgsimJy9f8inOVvwR5hKQn4AUI-Iyw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16188531</pqid></control><display><type>article</type><title>Specific Antibody Profile in Human Brucellosis</title><source>Jstor Complete Legacy</source><source>MEDLINE</source><source>Oxford University Press Journals Digital Archive Legacy</source><creator>Ariza, J. ; Pellicer, T. ; Pallarés, R. ; Foz, A. ; Gudiol, F.</creator><creatorcontrib>Ariza, J. ; Pellicer, T. ; Pallarés, R. ; Foz, A. ; Gudiol, F.</creatorcontrib><description>The results of classic serological tests were compared with those of enzyme-linked immunosor-bent assay in studies of immunoglobulins to Brucella in 761 serum samples from 75 patients with brucellosis. Except for five instances involving the IgM ELISA, all serological tests gave positive results at admission. Among the 63 patients without relapse, rates of persistent ELISA positivity (determined by the Kaplan-Meier method) 12 months after therapy were 25% for IgM, 69% for IgA, and 89% for IgG. Among the 12 patients with relapse, a second peak of ELISA IgG and IgA was often detected. The persistence of high serum antibody titers in patients without relapse was due mainly to IgG and was often associated with high titers at admission or with the presence of focal disease. Overall, serological changes were better detected by ELISA than by classic serological tests. While a second peak of ELISA IgG and IgA is a good marker of relapse, the persistence of high titers of IgG by itself is not a good predictor of chronic infection.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1093/clinids/14.1.131</identifier><identifier>PMID: 1571417</identifier><language>eng</language><publisher>United States: The University of Chicago Press</publisher><subject>Adolescent ; Adult ; Aged ; Aged, 80 and over ; Agglutination ; Agglutination Tests ; Antibodies ; Antibodies, Bacterial - blood ; Brucella ; Brucella - immunology ; Brucellosis ; Brucellosis - immunology ; Child ; Clinical Infectious Disease Articles ; Coombs Test ; Enzyme linked immunosorbent assay ; Female ; Hospital admissions ; Humans ; Immunoglobulin A - blood ; Immunoglobulin G - blood ; Immunoglobulin M - blood ; Immunoglobulins ; Immunoglobulins - blood ; Male ; Middle Aged ; Recurrence ; Relapse</subject><ispartof>Clinical infectious diseases, 1992-01, Vol.14 (1), p.131-140</ispartof><rights>Copyright 1992 The University of Chicago</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c450t-6847355ceb211a82ad73e3d4d10f6dcdbcaff634fc29b2c336761efd72ed0b303</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4456252$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4456252$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,776,780,799,27901,27902,57992,58225</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/1571417$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ariza, J.</creatorcontrib><creatorcontrib>Pellicer, T.</creatorcontrib><creatorcontrib>Pallarés, R.</creatorcontrib><creatorcontrib>Foz, A.</creatorcontrib><creatorcontrib>Gudiol, F.</creatorcontrib><title>Specific Antibody Profile in Human Brucellosis</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><description>The results of classic serological tests were compared with those of enzyme-linked immunosor-bent assay in studies of immunoglobulins to Brucella in 761 serum samples from 75 patients with brucellosis. Except for five instances involving the IgM ELISA, all serological tests gave positive results at admission. Among the 63 patients without relapse, rates of persistent ELISA positivity (determined by the Kaplan-Meier method) 12 months after therapy were 25% for IgM, 69% for IgA, and 89% for IgG. Among the 12 patients with relapse, a second peak of ELISA IgG and IgA was often detected. The persistence of high serum antibody titers in patients without relapse was due mainly to IgG and was often associated with high titers at admission or with the presence of focal disease. Overall, serological changes were better detected by ELISA than by classic serological tests. While a second peak of ELISA IgG and IgA is a good marker of relapse, the persistence of high titers of IgG by itself is not a good predictor of chronic infection.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Agglutination</subject><subject>Agglutination Tests</subject><subject>Antibodies</subject><subject>Antibodies, Bacterial - blood</subject><subject>Brucella</subject><subject>Brucella - immunology</subject><subject>Brucellosis</subject><subject>Brucellosis - immunology</subject><subject>Child</subject><subject>Clinical Infectious Disease Articles</subject><subject>Coombs Test</subject><subject>Enzyme linked immunosorbent assay</subject><subject>Female</subject><subject>Hospital admissions</subject><subject>Humans</subject><subject>Immunoglobulin A - blood</subject><subject>Immunoglobulin G - blood</subject><subject>Immunoglobulin M - blood</subject><subject>Immunoglobulins</subject><subject>Immunoglobulins - blood</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Recurrence</subject><subject>Relapse</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1992</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkM1Lw0AUxBdRaq3ePSjk5C3tvuxXcqzFWrGiUAXxsiT7AVvTpO4mYP97W1Pq0dMb-M0Mj0HoEvAQcEZGqnSV02EEdAhDIHCE-sCIiDnL4HirMUtjmpL0FJ2FsMQYIMWsh3rABFAQfTRcrI1y1qloXDWuqPUmevG1daWJXBXN2lVeRbe-VaYs6-DCOTqxeRnMxf4O0Nv07nUyi-fP9w-T8TxWlOEm5ikVhDFligQgT5NcC2KIphqw5VrpQuXWckKtSrIiUYRwwcFYLRKjcUEwGaCbrnft66_WhEauXNg9kVemboMUSYYzTum_RuCQpozA1og7o_J1CN5YufZulfuNBCx3W8r9lhKoBAm_ket9d1usjP4LdONt-VXHl6Gp_QFTynjCki2OO-xCY74POPefkgsimJy9f8inOVvwR5hKQn4AUI-Iyw</recordid><startdate>199201</startdate><enddate>199201</enddate><creator>Ariza, J.</creator><creator>Pellicer, T.</creator><creator>Pallarés, R.</creator><creator>Foz, A.</creator><creator>Gudiol, F.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7T5</scope><scope>C1K</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>199201</creationdate><title>Specific Antibody Profile in Human Brucellosis</title><author>Ariza, J. ; Pellicer, T. ; Pallarés, R. ; Foz, A. ; Gudiol, F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c450t-6847355ceb211a82ad73e3d4d10f6dcdbcaff634fc29b2c336761efd72ed0b303</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1992</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Agglutination</topic><topic>Agglutination Tests</topic><topic>Antibodies</topic><topic>Antibodies, Bacterial - blood</topic><topic>Brucella</topic><topic>Brucella - immunology</topic><topic>Brucellosis</topic><topic>Brucellosis - immunology</topic><topic>Child</topic><topic>Clinical Infectious Disease Articles</topic><topic>Coombs Test</topic><topic>Enzyme linked immunosorbent assay</topic><topic>Female</topic><topic>Hospital admissions</topic><topic>Humans</topic><topic>Immunoglobulin A - blood</topic><topic>Immunoglobulin G - blood</topic><topic>Immunoglobulin M - blood</topic><topic>Immunoglobulins</topic><topic>Immunoglobulins - blood</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Recurrence</topic><topic>Relapse</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ariza, J.</creatorcontrib><creatorcontrib>Pellicer, T.</creatorcontrib><creatorcontrib>Pallarés, R.</creatorcontrib><creatorcontrib>Foz, A.</creatorcontrib><creatorcontrib>Gudiol, F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Immunology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ariza, J.</au><au>Pellicer, T.</au><au>Pallarés, R.</au><au>Foz, A.</au><au>Gudiol, F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Specific Antibody Profile in Human Brucellosis</atitle><jtitle>Clinical infectious diseases</jtitle><addtitle>Clinical Infectious Diseases</addtitle><date>1992-01</date><risdate>1992</risdate><volume>14</volume><issue>1</issue><spage>131</spage><epage>140</epage><pages>131-140</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><abstract>The results of classic serological tests were compared with those of enzyme-linked immunosor-bent assay in studies of immunoglobulins to Brucella in 761 serum samples from 75 patients with brucellosis. Except for five instances involving the IgM ELISA, all serological tests gave positive results at admission. Among the 63 patients without relapse, rates of persistent ELISA positivity (determined by the Kaplan-Meier method) 12 months after therapy were 25% for IgM, 69% for IgA, and 89% for IgG. Among the 12 patients with relapse, a second peak of ELISA IgG and IgA was often detected. The persistence of high serum antibody titers in patients without relapse was due mainly to IgG and was often associated with high titers at admission or with the presence of focal disease. Overall, serological changes were better detected by ELISA than by classic serological tests. While a second peak of ELISA IgG and IgA is a good marker of relapse, the persistence of high titers of IgG by itself is not a good predictor of chronic infection.</abstract><cop>United States</cop><pub>The University of Chicago Press</pub><pmid>1571417</pmid><doi>10.1093/clinids/14.1.131</doi><tpages>10</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 1992-01, Vol.14 (1), p.131-140 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72909644 |
| source | Jstor Complete Legacy; MEDLINE; Oxford University Press Journals Digital Archive Legacy |
| subjects | Adolescent Adult Aged Aged, 80 and over Agglutination Agglutination Tests Antibodies Antibodies, Bacterial - blood Brucella Brucella - immunology Brucellosis Brucellosis - immunology Child Clinical Infectious Disease Articles Coombs Test Enzyme linked immunosorbent assay Female Hospital admissions Humans Immunoglobulin A - blood Immunoglobulin G - blood Immunoglobulin M - blood Immunoglobulins Immunoglobulins - blood Male Middle Aged Recurrence Relapse |
| title | Specific Antibody Profile in Human Brucellosis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-08T07%3A13%3A37IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Specific%20Antibody%20Profile%20in%20Human%20Brucellosis&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Ariza,%20J.&rft.date=1992-01&rft.volume=14&rft.issue=1&rft.spage=131&rft.epage=140&rft.pages=131-140&rft.issn=1058-4838&rft.eissn=1537-6591&rft_id=info:doi/10.1093/clinids/14.1.131&rft_dat=%3Cjstor_proqu%3E4456252%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16188531&rft_id=info:pmid/1571417&rft_jstor_id=4456252&rfr_iscdi=true |